New Compassionate Access Pharmaceutical Scheme
AstraZeneca have announced a new compassionate access scheme to give more women access to Olaparib sooner. AstraZeneca’s compassionate access scheme gives newly diagnosed women with high-grade serous ovarian cancer (including fallopian and peritoneal) who also have a germline BRCA mutation (about 20-25% of high-grade serous) and whose cancer responds to platinum-based chemotherapy access to Olaparib […]
Pae Ora (Healthy Futures) Bill – Oral Submission
Late last year, we submitted on behalf of the New Zealand ovarian cancer community to recommend improvements to the Pae Ora (Healthy Futures) Bill. New Zealand’s public health system is fragmented, inequitable and inconsistent. For some population groups, in particular Māori, Pacific peoples and people with disabilities, rare disorders and women, this results in poorer […]
12 Ways Your Support Helped Ovarian Cancer In 2021
We are so proud of all the incredible things our donors, fundraisers and supporters have helped us achieve in the past year. Together, we are making huge strides to diagnose women earlier, treat them better ,and improve survival to help women live better, longer lives. In 2021, you helped us: Get ovarian cancer symptoms posters […]
Open letter to PHARMAC Review Panel
To the Pharmac Review Panel On behalf of CANGO (The Alliance of Cancer NGOs) we would like to acknowledge our full support of the review of Pharmac – the first independent assessment of Pharmac since its creation over 25 years ago. We recognise the Pharmac Review Panel’s difficult task in determining recommendations to Pharmac’s systems […]
Open Letter: Accelerate PHARMAC Innovation Funding
Cure Our Ovarian Cancer believes we need to protect cancer patients and hospital resources in the time of Covid-19. IV chemotherapy is resource-intensive and immunosuppressive, which takes hours of hospital time to administer and increases vulnerability to Covid complications. In contrast, PARP inhibitors and Trametinib are tablets that are able to be taken at home, […]
Three Women Cycle, Run And Walk 1000km For Cure Our Ovarian Cancer
Focus Magazine recently shared Kate’s experiences of ovarian cancer and her incredible friends who took our September Step Up Challenge to the next level to support our crucial work. We are so grateful to Kate, Amanda, Carmen and Laura, and all of their supporters. Written for and published by Focus Magazine on October 1, 2021 […]
Ovarian Cancer NZ 2021 Research Grant Calls For Applicants
Cure Our Ovarian Cancer is pleased to announce applications for our third research granting round have opened. We are calling for researchers investigating low-grade serous ovarian cancer, a type of cancer that disproportionately affects young Kiwi’s to apply for the $25,000 research grant. Specifically, research has the potential to directly benefit New Zealanders affected and/or […]
Woman Died From Ovarian Cancer After Being Told She Likely Had An STI
Story originally written for and published by Stuff.Read the full story here. A woman died of ovarian cancer after being sent home from the emergency department and told she likely had chlamydia. The family of Amy Meyer, 36, believe if doctors had listened to her concerns, she might still be alive. “The system is broken […]
Help Stop Women From Dying
The Government’s pre-budget promise of a multi-million dollar injection into breast and cervical cancer screening has prompted calls for more funding to treat more cancers. Ovarian cancer is the fifth leading cause of cancer death in New Zealand women but many women struggle to get an accurate diagnosis before it’s too late to treat. Jane […]
Ovarian Cancer Petition: Thousands Call For Better Diagnosis, Funding
Article written by Emma Hatton for RNZ Read the full article here Last year deaths from ovarian cancer topped the number of women killed on our roads, yet people with the disease say it is an ignored crisis. Today a petition with more than 7,000 signatures, calling for national diagnostic guidelines to be developed, better […]